CD47 blockade inhibits tumor progression human osteosarcoma in xenograft models

Osteosarcoma is the most common bone tumors in children and adolescents. Despite intensive chemotherapy, patients with advanced disease still have a poor prognosis, illustrating the need for alternative therapies. In this study, we explored the use of antibodies that block CD47 with a tumor growth s...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Ji-Feng, Pan, Xiao-Hong, Zhang, Shui-Jun, Zhao, Chen, Qiu, Bin-Song, Gu, Hai-Feng, Hong, Jian-Fei, Cao, Li, Chen, Yu, Xia, Bing, Bi, Qin, Wang, Ya-Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4695143/
https://www.ncbi.nlm.nih.gov/pubmed/26093091

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4695143/
https://www.ncbi.nlm.nih.gov/pubmed/26093091

Ejemplares similares